AdityaMehtaMD Profile Banner
Aditya Mehta Profile
Aditya Mehta

@AdityaMehtaMD

Followers
53
Following
26
Media
1
Statuses
11

Heart failure and Transplant fellow @UofUtah | Cardiology @ISHVnews | @WMUmedicine and @MAMC_NewDelhi alumni. HF enthusiast

Salt Lake City, UT
Joined May 2025
Don't wanna be here? Send us removal request.
@JCardFail
Journal of Cardiac Failure
22 hours
Also, don’t miss the accompanying editorial, which analyzes the article and advocates for the integration of dietary assessment & counseling in routine CV care. The daily decisions our patients make at the grocery store, restaurants, and home matter! 🔗 https://t.co/e99j8N2ITg
0
5
7
@JCardFail
Journal of Cardiac Failure
22 hours
🚨Can diet influence risk of HF? 📌Analysis of 17,975 pts in the REGARDS cohort, median follow-up 11.1 y 📌Dietary Inflammatory Score (DIS)= measures inflammatory potential of diet 📌Pro-inflammatory diets (highest DIS quartile) ⬆️ risk of incident HF 🔗 https://t.co/7K8EqrFueI
2
9
17
@docbhardwaj
Anju Bhardwaj MD FACC
7 days
🏷️ #AMR remains key challenge in #HT 🫀 🎯 Read emerging insights and evolving management strategies shaping contemporary care in @JACCJournals #JACCHF by @PalakShahMD @AdityaMehtaMD @EMDeFilippisMD @JosefStehlik #AnnetteJackson #JonKobashigawa 👉 https://t.co/L92D4FCimN
2
7
29
@ISHVnews
Inova Schar Heart and Vascular
2 months
In #JACCHF Position Statement, @AdityaMehtaMD @PalakShahMD address diagnostic and therapeutic approaches for AMR in Heart Transplantation, and discuss unresolved questions and issues @coconnormd @JACCJournals https://t.co/J5U8OpvHZg
0
13
39
@AdityaMehtaMD
Aditya Mehta
2 months
Now published in @TheJHLT, our 2-year outcomes of the DOAC-LVAD phase 2 study done at @ISHVnews adding to the current understanding of use of DOACs in LVAD patients!! Need for phase 3 multi-center RCT https://t.co/XoTOfbymg5
0
3
19
@AdityaMehtaMD
Aditya Mehta
2 months
Thank you team for collaborating on this complex issue in HTx with so much heterogeneity in management across centers. @PalakShahMD @JosefStehlik @Annette_HLA @EMDeFilippisMD #JonKobashigawa
@EMDeFilippisMD
Silia DeFilippis MD FACC FAHA FHFSA
2 months
Congrats to @AdityaMehtaMD for leading this Position Statement in @JACCJournals #JACCHF re: contemporary approach to AMR after HTx 🫀 With the ⬆️ use of molecular diagnostics and multimodality imaging, we are increasingly recognizing subclinical and pre-clinical cases of AMR
0
1
2
@KayEverettMDPhD
Kay Everett, MD, PhD
5 months
Congratulations to all #GRS Assisted Circulation presenters and thank you to our mentors - all made this a GRS to remember! Thank you to my cochair Andi Escher - so proud of this incredible program! Here’s to new colleagues, incredible science and GRS 2027!
2
6
22
@ISHVnews
Inova Schar Heart and Vascular
10 months
Working toward determining optimal treating strategies for SCAI Stage E CS @agtruesdell @AdityaMehtaMD @ilanvavilinmd discuss Hanson et al analysis of RECOVER III Study AMICS responders vs nonresponders to PCI @MyJSCAI https://t.co/pGa0d0nD7b https://t.co/MwTflgiWlP
1
4
4
@ISHVnews
Inova Schar Heart and Vascular
7 months
In @TheJHLT @AdityaMehtaMD @JasonGoldbergMD @PalakShahMD, et al looked at interrater variability & examined clinical implications of elevated donor-derived cell-free DNA beyond AR GRAfT Investigators @coconnormd @ISHLT https://t.co/g43ydT6OUB
0
9
13